Avadel Pharmaceuticals plc

Q4 2025 13F Holders

Symbol
AVDL
CUSIP
G29687103
Type
Equity
Class
COM SHS
Num filings
228
Total reported value, excl. options
$1.59 B
Manager Report Date Value ($000) Shares Option Type